The efficacy of adding Boswellia serrata
Phase 3
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20101130005280N48
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All patients with a confirmed diagnosis of schizophrenia according to DSM5
Age range 18 to 36 years
Completion of the consent form by their legal guardian.
Patients should have a trusted caregiver who monitors the patient's medication use.
Education level: At least 8 classes.
Exclusion Criteria
Existence of serious accompanying cognitive disorders.
Having other psychiatric disorders.
Existence of other medical diseases that affect cognition, such as head trauma and epilepsy
Consumption of substances other than cigarettes
Pregnant or lactating patient
Do not have the ability and focus to perform tests
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient quality of life. Timepoint: Before the intervention and after 3 months of drug use. Method of measurement: PANSS tests, stroop test, digit span, wisconsin, Wechsler memory.
- Secondary Outcome Measures
Name Time Method